Merit Medical Systems Q2 2024 Adj EPS $0.92 Beats $0.87 Estimate, Sales $338.00M Beat $334.55M Estimate
Merit Medical Systems Q2 2024 Adj EPS $0.92 Beats $0.87 Estimate, Sales $338.00M Beat $334.55M Estimate
Merit Medical Systems 2024年第二季度每股收益$0.92，超出預期的$0.87，銷售額爲$33800萬，超出預期的$33455萬。
Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.87 by 5.75 percent. The company reported quarterly sales of $338.00 million which beat the analyst consensus estimate of $334.55 million by 1.03 percent. This is a 5.61 percent increase over sales of $320.06 million the same period last year.
Merit Medical Systems (納斯達克:MMSI)報告每股盈利爲$0.92，超出分析師共識預估($0.87)5.75%。公司報告季度銷售額爲$3,3800萬，超出分析師共識預估($3,3455萬)1.03%。這是相對於去年同期銷售額$3,2006萬的增長5.61%。